A phase I study of doxifluridine as a five-day stepped-dose continuous infusion. | Am J Clin Oncol;13(4): 308-11, 1990 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

A phase I study of doxifluridine as a five-day stepped-dose continuous infusion.

Olver, I N; Reece, P A; Bishop, J F; Morris, R G; Hillcoat, B L; Guentert, T W.

Affiliation

Olver IN; Department of Cancer Medicine, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.

Am J Clin Oncol ; 13(4): 308-11, 1990 Aug.

Article in En | MEDLINE | ID: mdl-2143051

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Floxuridine / Neoplasms / Antineoplastic Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Clin Oncol Year: 1990 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Floxuridine / Neoplasms / Antineoplastic Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Clin Oncol Year: 1990 Document type: Article Affiliation country: